North American Pharma & Life Sciences M&A Update

View this page in: Français

This publication is PwC’s newsletter providing details on mergers and acquisitions in the pharmaceutical, life sciences and biotechnology industries.

PwCCF’s North American Pharma & Life Sciences Deals Update – 2H 2011
Despite being a defensive sector, the North American Pharma & Life Sciences industry was not immune to the general slowdown in M&A activity seen in the second half of 2011.

PwCCF’s North American Pharma & Life Sciences Deals Update – Q1 2011
M&A activity in the North American Pharma & Life Sciences industry started strong in 2011 with 101 announced deals in the first quarter.

PwCCF’s North American Pharma & Life Sciences Deals Update – Q4 2010
The last quarter of the year saw a significant jump in M&A activity in the North American Pharma & Life Sciences industry, with 84 announced deals.

PwCCF’s North American Pharma & Life Sciences Deals Update – Q3 2010
While the total number of deals in Q3 2010 is down 10% to 63 from last quarter, it remained above Q1 2010 activity by almost 20%.

PwCCF’s North American Pharma & Life Sciences Deals Update – July 2010
M&A activity in the North American pharma and life sciences sector continued to gain momentum in Q2 2010 ending the quarter up 32% from Q1 2010 levels.

North American Pharma & Life Sciences M&A Update – March 2010
There was a sizeable jump in deal announcements in the pharma and life sciences sector in March, with 22 deals as compared to February’s 17.

North American Pharma & Life Sciences M&A Update – February 2010
Deal activity in the pharma and life sciences sector crept up slightly from January’s levels with 17 announced deals in the month.

North American Pharma & Life Sciences M&A Update – January 2010
Activity in the pharma and life sciences sector took a breather from the robust levels of the fourth quarter of 2009, announcing 14 deals in the month of January.

North American Pharma & Life Sciences M&A Update – December 2009
There was a jump in M&A activity in December in the North American pharma and life sciences sector with 36 announced deals – up over 50% from November’s 23 announced deals.

North American Pharma & Life Sciences M&A Update – November 2009
Momentum in M&A activity continued through November in the North American pharma and life sciences sector with 23 announced transactions this month. Canadian companies were involved in three deals.

North American Pharma & Life Sciences M&A Update – October 2009
This publication looks at transactions announced in the month of October by North American-based companies in the pharmaceuticals and life sciences industry.